azomycin has been researched along with nla 1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomer, WD; Mainwaring, A; Papadopoulou, MV | 1 |
| Bloomer, WD; Epperly, MW; Papadopoulou, MV; Shields, DS | 1 |
| Anderson, RF; Brown, JM; Denny, WA; Phil, D; Roberts, PB; Wilson, WR | 1 |
| Bloomer, WD; Doddi, M; Papadopoulou, MV; Rosenzweig, HS | 1 |
4 other study(ies) available for azomycin and nla 1
| Article | Year |
|---|---|
Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agents.
Topics: Aminoacridines; Animals; Cell Line; Cell Survival; Chelating Agents; Dose-Response Relationship, Drug; Drug Synergism; Kinetics; Lomustine; Mathematics; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
Topics: Aminoacridines; Animals; Cell Hypoxia; Cell Line; Cell Survival; Kinetics; Molecular Structure; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Topics: Aminoacridines; Animals; Cell Hypoxia; Cell Line; Combined Modality Therapy; DNA; DNA, Neoplasm; Intercalating Agents; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Topics: Aerobiosis; Aminoacridines; Animals; Cell Hypoxia; Cells, Cultured; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Intercalating Agents; Lung; Nitroimidazoles; Radiation-Sensitizing Agents; Tacrine | 1994 |